Tobias Puengel
Stiftung Charité · 70 works · 2,495 citations · h-index 18
Top works
- Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
- Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury
- An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
- Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆
- Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis
- Acquisition of epithelial plasticity in human chronic liver disease
- Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury
- The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis
- The Dual Ccr2/Ccr5 Antagonist Cenicriviroc Ameliorates Steatohepatitis and Fibrosis in Vivo by Inhibiting the Infiltration of Inflammatory Monocytes into Injured Liver
- Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease
- Skeletal Muscle Composition Predicts Outcome in Critically Ill Patients
- Thyroid hormones as a disease modifier and therapeutic target in nonalcoholic steatohepatitis
- Combined Therapy with a CCR2/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and Fibrosis
- Association of Serum Calprotectin Concentrations with Mortality in Critically Ill and Septic Patients
- Repair macrophages in acute liver failure
- Pharmacotherapeutic options for metabolic dysfunction-associated steatotic liver disease: where are we today?
- Dissecting Acute Drug‐Induced Hepatotoxicity and Therapeutic Responses of Steatotic Liver Disease Using Primary Mouse Liver and Blood Cells in a Liver‐On‐A‐Chip Model
- Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular Carcinoma
- Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression
- CT-based determination of excessive visceral adipose tissue is associated with an impaired survival in critically ill patients